Beeson Summer A, Neubauer Daniel, Calvo Richard, Sise Michael, Martin Matthew, Kauvar David S, Reid Chris M
Department of Surgery, Division of Plastic and Reconstructive Surgery, University of California San Diego, San Diego, Calif.
Department of Surgery, Naval Medical Center San Diego, San Diego, Calif.
Plast Reconstr Surg Glob Open. 2023 Jan 11;11(1):e4727. doi: 10.1097/GOX.0000000000004727. eCollection 2023 Jan.
Mortality rates following major lower extremity amputations (LEAs) 30 days-365 days postoperative have decreased, but 5-year rates remain high at 40.4%-70%. These data may not reflect recent advances in peripheral arterial disease (PAD) care, and comorbidities of chronic PAD may lead to mortality more frequently than the amputation itself. Mortality rates between diabetic and nondiabetic patients were also analyzed.
The California Office of Statewide Health Planning and Development hospital database was queried for patients admitted January 1, 2007-December 31, 2018. ICD-9-CM codes identified patients with vascular disease and an amputation procedure.
There were 26,669 patients. The 30-day, 90-day, 1-year, and 5-year major LEA mortality rates were 4.82%, 8.62%, 12.47%, and 18.11%, respectively. Weighted averages of 30-day, 90-day, 1-year, and 5-year major LEA mortality rates in the literature are 13%, 15.40%, 47.93%, and 60.60%, respectively. Mortality risk associated with vascular disease after amputation (hazard ratio = 22.07) was 11 times greater than risk associated with amputation-specific complications from impaired mobility (hazard ratio = 1.90; < 0.01). Having diabetes was associated with lower mortality at 30 days, 90 days, and 1 year ( < 0.01) but not at 5 years ( = 0.22).
This study suggests that people may be living longer after their major LEA than was previously thought. This study suggests that patients' PAD may play a bigger role in contributing to their mortality than complications from loss of mobility postamputation. Although having diabetes was associated with lower postamputation mortality, the difference was no longer significant by 5 years.
下肢大截肢术后30天至365天的死亡率有所下降,但5年死亡率仍高达40.4% - 70%。这些数据可能无法反映外周动脉疾病(PAD)护理的最新进展,慢性PAD的合并症可能比截肢本身更频繁地导致死亡。还分析了糖尿病患者和非糖尿病患者之间的死亡率。
查询加利福尼亚州全州卫生规划与发展办公室医院数据库中2007年1月1日至2018年12月31日入院的患者。ICD - 9 - CM编码识别患有血管疾病并接受截肢手术的患者。
共有26669名患者。下肢大截肢术后30天、90天、1年和5年的死亡率分别为4.82%、8.62%、12.47%和18.11%。文献中下肢大截肢术后30天、90天、1年和5年死亡率的加权平均值分别为13%、15.40%、47.93%和60.60%。截肢后与血管疾病相关的死亡风险(风险比 = 22.07)比与行动不便导致的截肢特异性并发症相关的风险(风险比 = 1.90;P < 0.01)高11倍。患有糖尿病与30天、90天和1年时较低的死亡率相关(P < 0.01),但与5年时的死亡率无关(P = 0.22)。
本研究表明下肢大截肢术后患者的存活时间可能比之前认为的更长。本研究表明,患者的PAD在导致其死亡方面可能比截肢后行动能力丧失引起的并发症起更大作用。虽然患有糖尿病与截肢后较低的死亡率相关,但到5年时这种差异不再显著。